AstraZeneca(AZN) Prnewswire·2025-03-17 12:04Core Insights - IgniteData has partnered with AstraZeneca and Cambridge University Hospitals NHS Foundation Trust to implement its Archer tool for clinical data integration in a Phase 3 study, marking a significant advancement in clinical trial automation and digital innovation [1][3] Company Overview - IgniteData is focused on transforming clinical trials through its Archer platform, which automates data transfer between Electronic Health Records (EHRs) and Electronic Data Capture (EDC) systems, enhancing efficiency and data integrity [2][5][6] Technology and Innovation - The Archer tool is designed to ensure high data security standards while facilitating the transfer of hundreds of data points per patient, allowing researchers to concentrate on clinical research rather than data entry [2][6] - The system-agnostic nature of Archer allows it to integrate seamlessly with various EHRs and EDCs, promoting interoperability in clinical research [2][6] Collaboration and Development - The collaboration began in 2021, with AstraZeneca playing a crucial role in developing the Archer platform, which has undergone successful pilot studies at notable institutions [3] - The integration of Archer into the EHR system at Cambridge University Hospitals is seen as a significant advancement in clinical trial processes, enhancing both efficiency and data integrity [3] Future Prospects - The insights gained from the current study will inform future deployments of Archer across NHS and European hospitals, aiming to scale the technology globally and improve the conduct of clinical trials [4]